Retinal Dystrophy Treatment Market, Global Outlook and Forecast 2024-2031

Report ID: 1068249 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Retinal Dystrophy Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Retinal Dystrophy Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Retinal Dystrophy Treatment Overall Market Size
    2.1 Global Retinal Dystrophy Treatment Market Size: 2021 VS 2028
    2.2 Global Retinal Dystrophy Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Retinal Dystrophy Treatment Players in Global Market
    3.2 Top Global Retinal Dystrophy Treatment Companies Ranked by Revenue
    3.3 Global Retinal Dystrophy Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Retinal Dystrophy Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Retinal Dystrophy Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Retinal Dystrophy Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Retinal Dystrophy Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Retinal Dystrophy Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Retinal Dystrophy Treatment Market Size Markets, 2021 & 2028
        4.1.2 Gene Therapy Treatment
        4.1.3 Symptomatic Treatment
    4.2 By Type - Global Retinal Dystrophy Treatment Revenue & Forecasts
        4.2.1 By Type - Global Retinal Dystrophy Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Retinal Dystrophy Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Retinal Dystrophy Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Specialty Clinics
        5.1.4 Others
    5.2 By Application - Global Retinal Dystrophy Treatment Revenue & Forecasts
        5.2.1 By Application - Global Retinal Dystrophy Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Retinal Dystrophy Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Retinal Dystrophy Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Retinal Dystrophy Treatment Revenue & Forecasts
        6.2.1 By Region - Global Retinal Dystrophy Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Retinal Dystrophy Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Retinal Dystrophy Treatment Revenue, 2017-2028
        6.3.2 US Retinal Dystrophy Treatment Market Size, 2017-2028
        6.3.3 Canada Retinal Dystrophy Treatment Market Size, 2017-2028
        6.3.4 Mexico Retinal Dystrophy Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Retinal Dystrophy Treatment Revenue, 2017-2028
        6.4.2 Germany Retinal Dystrophy Treatment Market Size, 2017-2028
        6.4.3 France Retinal Dystrophy Treatment Market Size, 2017-2028
        6.4.4 U.K. Retinal Dystrophy Treatment Market Size, 2017-2028
        6.4.5 Italy Retinal Dystrophy Treatment Market Size, 2017-2028
        6.4.6 Russia Retinal Dystrophy Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Retinal Dystrophy Treatment Market Size, 2017-2028
        6.4.8 Benelux Retinal Dystrophy Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Retinal Dystrophy Treatment Revenue, 2017-2028
        6.5.2 China Retinal Dystrophy Treatment Market Size, 2017-2028
        6.5.3 Japan Retinal Dystrophy Treatment Market Size, 2017-2028
        6.5.4 South Korea Retinal Dystrophy Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Retinal Dystrophy Treatment Market Size, 2017-2028
        6.5.6 India Retinal Dystrophy Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Retinal Dystrophy Treatment Revenue, 2017-2028
        6.6.2 Brazil Retinal Dystrophy Treatment Market Size, 2017-2028
        6.6.3 Argentina Retinal Dystrophy Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Retinal Dystrophy Treatment Revenue, 2017-2028
        6.7.2 Turkey Retinal Dystrophy Treatment Market Size, 2017-2028
        6.7.3 Israel Retinal Dystrophy Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Retinal Dystrophy Treatment Market Size, 2017-2028
        6.7.5 UAE Retinal Dystrophy Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Spark Therapeutics (Roche)
        7.1.1 Spark Therapeutics (Roche) Corporate Summary
        7.1.2 Spark Therapeutics (Roche) Business Overview
        7.1.3 Spark Therapeutics (Roche) Retinal Dystrophy Treatment Major Product Offerings
        7.1.4 Spark Therapeutics (Roche) Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.1.5 Spark Therapeutics (Roche) Key News
    7.2 Novartis AG
        7.2.1 Novartis AG Corporate Summary
        7.2.2 Novartis AG Business Overview
        7.2.3 Novartis AG Retinal Dystrophy Treatment Major Product Offerings
        7.2.4 Novartis AG Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.2.5 Novartis AG Key News
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Corporate Summary
        7.3.2 GlaxoSmithKline Business Overview
        7.3.3 GlaxoSmithKline Retinal Dystrophy Treatment Major Product Offerings
        7.3.4 GlaxoSmithKline Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.3.5 GlaxoSmithKline Key News
    7.4 Applied Genetic Technologies Corporation
        7.4.1 Applied Genetic Technologies Corporation Corporate Summary
        7.4.2 Applied Genetic Technologies Corporation Business Overview
        7.4.3 Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Major Product Offerings
        7.4.4 Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.4.5 Applied Genetic Technologies Corporation Key News
    7.5 Oxford BioMedica
        7.5.1 Oxford BioMedica Corporate Summary
        7.5.2 Oxford BioMedica Business Overview
        7.5.3 Oxford BioMedica Retinal Dystrophy Treatment Major Product Offerings
        7.5.4 Oxford BioMedica Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.5.5 Oxford BioMedica Key News
    7.6 Biogen
        7.6.1 Biogen Corporate Summary
        7.6.2 Biogen Business Overview
        7.6.3 Biogen Retinal Dystrophy Treatment Major Product Offerings
        7.6.4 Biogen Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.6.5 Biogen Key News
    7.7 HORAMA S.A.
        7.7.1 HORAMA S.A. Corporate Summary
        7.7.2 HORAMA S.A. Business Overview
        7.7.3 HORAMA S.A. Retinal Dystrophy Treatment Major Product Offerings
        7.7.4 HORAMA S.A. Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.7.5 HORAMA S.A. Key News
    7.8 MeiraGTx Limited
        7.8.1 MeiraGTx Limited Corporate Summary
        7.8.2 MeiraGTx Limited Business Overview
        7.8.3 MeiraGTx Limited Retinal Dystrophy Treatment Major Product Offerings
        7.8.4 MeiraGTx Limited Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.8.5 MeiraGTx Limited Key News
    7.9 Novelion Therapeutics
        7.9.1 Novelion Therapeutics Corporate Summary
        7.9.2 Novelion Therapeutics Business Overview
        7.9.3 Novelion Therapeutics Retinal Dystrophy Treatment Major Product Offerings
        7.9.4 Novelion Therapeutics Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.9.5 Novelion Therapeutics Key News
    7.10 IVERIC bio
        7.10.1 IVERIC bio Corporate Summary
        7.10.2 IVERIC bio Business Overview
        7.10.3 IVERIC bio Retinal Dystrophy Treatment Major Product Offerings
        7.10.4 IVERIC bio Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.10.5 IVERIC bio Key News
    7.11 Reflection Biotechnologies
        7.11.1 Reflection Biotechnologies Corporate Summary
        7.11.2 Reflection Biotechnologies Business Overview
        7.11.3 Reflection Biotechnologies Retinal Dystrophy Treatment Major Product Offerings
        7.11.4 Reflection Biotechnologies Retinal Dystrophy Treatment Revenue in Global Market (2017-2022)
        7.11.5 Reflection Biotechnologies Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Retinal Dystrophy Treatment Market Opportunities & Trends in Global Market
    Table 2. Retinal Dystrophy Treatment Market Drivers in Global Market
    Table 3. Retinal Dystrophy Treatment Market Restraints in Global Market
    Table 4. Key Players of Retinal Dystrophy Treatment in Global Market
    Table 5. Top Retinal Dystrophy Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Retinal Dystrophy Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Retinal Dystrophy Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Retinal Dystrophy Treatment Product Type
    Table 9. List of Global Tier 1 Retinal Dystrophy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Retinal Dystrophy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Retinal Dystrophy Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Retinal Dystrophy Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Retinal Dystrophy Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Retinal Dystrophy Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Retinal Dystrophy Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Retinal Dystrophy Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Retinal Dystrophy Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Retinal Dystrophy Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Retinal Dystrophy Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Retinal Dystrophy Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Retinal Dystrophy Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Retinal Dystrophy Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Retinal Dystrophy Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Retinal Dystrophy Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Spark Therapeutics (Roche) Corporate Summary
    Table 31. Spark Therapeutics (Roche) Retinal Dystrophy Treatment Product Offerings
    Table 32. Spark Therapeutics (Roche) Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis AG Corporate Summary
    Table 34. Novartis AG Retinal Dystrophy Treatment Product Offerings
    Table 35. Novartis AG Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. GlaxoSmithKline Corporate Summary
    Table 37. GlaxoSmithKline Retinal Dystrophy Treatment Product Offerings
    Table 38. GlaxoSmithKline Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Applied Genetic Technologies Corporation Corporate Summary
    Table 40. Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Product Offerings
    Table 41. Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Oxford BioMedica Corporate Summary
    Table 43. Oxford BioMedica Retinal Dystrophy Treatment Product Offerings
    Table 44. Oxford BioMedica Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Biogen Corporate Summary
    Table 46. Biogen Retinal Dystrophy Treatment Product Offerings
    Table 47. Biogen Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. HORAMA S.A. Corporate Summary
    Table 49. HORAMA S.A. Retinal Dystrophy Treatment Product Offerings
    Table 50. HORAMA S.A. Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. MeiraGTx Limited Corporate Summary
    Table 52. MeiraGTx Limited Retinal Dystrophy Treatment Product Offerings
    Table 53. MeiraGTx Limited Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Novelion Therapeutics Corporate Summary
    Table 55. Novelion Therapeutics Retinal Dystrophy Treatment Product Offerings
    Table 56. Novelion Therapeutics Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. IVERIC bio Corporate Summary
    Table 58. IVERIC bio Retinal Dystrophy Treatment Product Offerings
    Table 59. IVERIC bio Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
    Table 60. Reflection Biotechnologies Corporate Summary
    Table 61. Reflection Biotechnologies Retinal Dystrophy Treatment Product Offerings
    Table 62. Reflection Biotechnologies Retinal Dystrophy Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Retinal Dystrophy Treatment Segment by Type in 2021
    Figure 2. Retinal Dystrophy Treatment Segment by Application in 2021
    Figure 3. Global Retinal Dystrophy Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Retinal Dystrophy Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Retinal Dystrophy Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Retinal Dystrophy Treatment Revenue in 2021
    Figure 8. By Type - Global Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 12. US Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 24. China Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Retinal Dystrophy Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Retinal Dystrophy Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Spark Therapeutics (Roche) Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis AG Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. GlaxoSmithKline Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Applied Genetic Technologies Corporation Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Oxford BioMedica Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Biogen Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. HORAMA S.A. Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. MeiraGTx Limited Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Novelion Therapeutics Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. IVERIC bio Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Reflection Biotechnologies Retinal Dystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Retinal Dystrophy Treatment Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Retinal Dystrophy Treatment Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Retinal Dystrophy Treatment Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports